Marpai (MRAI) Q2 2024 earnings summary

Executive summary

• Revenue declined 28% year-over-year to $7.2 million for Q2 2024, primarily due to customer turnover and market evolution.

• Net loss widened to $13.0 million in Q2 2024, up 72% from Q2 2023, driven by a $7.6 million impairment charge.

• Leadership is focused on a turnaround with profitable growth, positive cash flow, and operational improvements.

• Management is reviewing strategic alternatives, including investment, merger, or sale, to maximize shareholder value.

• Company transitioned its stock listing from Nasdaq to OTCQX in May 2024.

Financial highlights

• Q2 2024 revenue was $7.2 million, down from $10.0 million in Q2 2023; six-month revenue was $14.6 million, down from $19.7 million.

• Operating loss for Q2 2024 was $12.3 million, up from $7.3 million in Q2 2023.

• Cash operating expenses were reduced by 38%, saving approximately $4 million.

• Net cash increased by $600,000 in Q2 2024, compared to a $2.3 million decrease in Q2 2023.

• Cash and cash equivalents at June 30, 2024, were $1.3 million, with restricted cash of $12.8 million and negative working capital of $1.5 million.

Outlook and guidance

• Leadership remains optimistic about achieving positive cash flow and continued growth, with a focus on operational improvements and cost-saving initiatives.

• Management is seeking additional capital through equity or debt to fund operations and investment needs.

• Substantial doubt exists about the company's ability to continue as a going concern over the next 12 months.

• Strategic alternatives under review may include investment, merger, or sale.

• Management expects to highlight the Q1 2025 sales pipeline after the third quarter.